[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Gantosj Joe Joe posts on X about $srpt, sarepta therapeutics, $atbpf, $lib the most. They currently have XXXXXX followers and 1561 posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::223589965/interactions)  - X Week XXXXXX +581% - X Month XXXXXX +57% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::223589965/posts_active)  - X Months XXX -XX% - X Year XXX -X% ### Followers: XXXXXX [#](/creator/twitter::223589965/followers)  - X Week XXXXXX +0.03% - X Month XXXXXX +0.19% - X Months XXXXXX +0.38% - X Year XXXXXX +2.20% ### CreatorRank: XXXXXXX [#](/creator/twitter::223589965/influencer_rank)  ### Social Influence [#](/creator/twitter::223589965/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [countries](/list/countries) **Social topic influence** [$srpt](/topic/$srpt) #180, [sarepta therapeutics](/topic/sarepta-therapeutics), [$atbpf](/topic/$atbpf), [$lib](/topic/$lib) #1, [$vltlf](/topic/$vltlf) #1, [$vrtx](/topic/$vrtx), [$ateto](/topic/$ateto), [$cricf](/topic/$cricf), [$criv](/topic/$criv), [longterm](/topic/longterm) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Vertex Protocol (VRTX)](/topic/$vrtx) [AST SpaceMobile, Inc. Class A Common Stock (ASTS)](/topic/$asts) ### Top Social Posts [#](/creator/twitter::223589965/posts) --- Top posts by engagements in the last XX hours "$VLTLF $LIB The results from the Field Trial confirmed the performance against the R&D Centre by achieving an average XX% lithium extraction rate from Bakkenregion oilfield brine. The field trial was conducted at Compass Energy Systems Blue Marlin salt-water-disposal facility #NorthDakota"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945899886005612763) 2025-07-17 17:34:20 UTC 13.3K followers, 3060 engagements "$CRI.v $CRICF continue to surprise the street with high grade Zinc results & up another XXXXX% today to C$0.095 on huge volume 3.2M shares Sophisticated mining investors are joining Churchill Reports High-Grade Zinc Results on Polymetallic Veinsat the Black Raven Property Central Newfoundland"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1942629401549574504) 2025-07-08 16:58:36 UTC 13.3K followers, 2042 engagements "$SRPT is eligible to receive up to $103.5M in near-term regulatory and commercial milestone payments Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS a Gene Therapy to Treat Duchenne Muscular Dystrophy"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1922287615845212397) 2025-05-13 13:47:36 UTC 13.3K followers, 2758 engagements "$SRPT Strategic restructuring includes reduced operating expenses delivering approximately $XXX million in anticipated annual cost savings and implementing a XX% workforce reduction of approximately XXX employees"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945575462442602737) 2025-07-16 20:05:11 UTC 13.3K followers, 11.2K engagements "$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945574961361346867) 2025-07-16 20:03:12 UTC 13.3K followers, 4058 engagements "Actually $ATBPF $ATE.to reiterate the Ph-2 "On track to launch upgraded Ph-2 abdominoplasty trial in March 2024" What I like about the Ph-2 in pain that it's fast to recruit & to get the data since the follow-up is for a very short period of X week. So results would be released in Q3"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1760309969717535098) 2024-02-21 14:26:16 UTC 13.3K followers, 2246 engagements "$CRI.v $CRICF Insiders are buying new CEO Conan bought 2million shares & holding total of 7.1M shares. Also Malik the largest shareholder bough another 1M shares to get a total of 34.46M shares Insiders can sell for multiple reasons but they will buy for only ONE reason CONFIDENCE in the company & LT opportunity Another #Polymetallic discovery in #Canada"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1943691955478622644) 2025-07-11 15:20:48 UTC 13.3K followers, 2008 engagements "Interesting $ATBPF $ATE.to is going for pivotal trial Ph-2 trial enhancements include the use of a placebo arm an increased sample size to XXX patient & the use of adaptive design methodology these enhancements may enable it to qualify as a pivotal trial for the FDA"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1757740456056590692) 2024-02-14 12:15:56 UTC 13.3K followers, 1524 engagements "The key to the kingdom is going to be onset. It's where $VRTX failed with VX-548 Ask yourself would you take a drug that needs X hours to show any meaningful effect after bunion surgery Or 2hrs after tummy-tuck surgery Patients will call the nurse every 10min $ATBPF 60min - Safe next-generation #NSAID with enhanced safety for stand-alone or multimodal use"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1752689325622362144) 2024-01-31 13:44:33 UTC 13.3K followers, 3662 engagements "$CNVIF $CNVI.v Capital structure Way undervalued when we look at many M&A deals in cardiovacular space & many large medical devices would try to get the hybrid device & add it to their imaging portfolio that gives CNVI a multibagger potential in a very short time"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1933227694164226144) 2025-06-12 18:19:34 UTC 13.3K followers, 4554 engagements "Just think about this #Undervalued & Under-The-Radar investment with a multibagger potential $VLTLF $LIB The Permian Basin in #Texas generates 19million barrels per day of brine at lithium concentrations avg. 30ppm translating to a conservative 170000 tonnes per annum of potential LCE. The Williston Basin Bakken in #NorthDakota production ranges from 1.6million to 2m barrels of brine per day suggesting potential production of 50000 tpa LCE. X Tonne of #Lithium in the US worth around $15K-20K"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945921650064593078) 2025-07-17 19:00:49 UTC 13.3K followers, 4857 engagements "$SRPT Sarepta Therapeutics Shares New Protein Expression and Safety Results from ENDEAVOR in Participants X Years Old at Time of Treatment"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1923363492377051157) 2025-05-16 13:02:45 UTC 13.3K followers, 7808 engagements "This non-opioid #pain drug in very interesting with potential to become Best-in-Class #NSAID with no to very low risk of GI AEs & bleeding #ulcer $ATBPF $ATE.to will start Ph-2 trial in Q1-2024 so any time during March is expected"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1759986651126775854) 2024-02-20 17:01:31 UTC 13.3K followers, 2507 engagements "$SRPT New protocol for immunosuppressive regimen with X months study"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945587228240957667) 2025-07-16 20:51:57 UTC 13.3K followers, 7895 engagements "When it comes to innovation & new technology investing in $VLTLF $LIB these days reminds me of the tough days $ASTS investors went through when short-sellers were steering the price & exploiting every delay or financing uncertainty. Back in April 2024 $ASTS plummeted to a 52-week low of $XXXX & fast forward to today ASTS become a favorite among loyal investors who held firm & kept averaging down. Now $ASTS trading at $XX with even more upside potential ahead its a reminder of the power of conviction and patience @spacanpanman @ASTS_SpaceMob @ASTS_Investors @fierro7676 @StunningFeline"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945930888740532676) 2025-07-17 19:37:32 UTC 13.3K followers, 4725 engagements "$SRPT Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs U.S. FDA has confirmed that screening and dosing may proceed in Study SRP-9005-101 for LGMD2C/R5"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1912122619026882929) 2025-04-15 12:35:32 UTC 13.3K followers, 4625 engagements "$SRPT Duchenne portfolio continues to deliver stable and robust revenues with preliminary quarterly results showing total net product revenue of $XXX million for the second quarter 2025"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1945575950030188858) 2025-07-16 20:07:08 UTC 13.3K followers, 13.5K engagements "$SRPT Sarepta Therapeutics to Announce First Quarter 2025 Financial Results Tuesday May X 2025. and conference call at 4:30pm ET"  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1914664914976727157) 2025-04-22 12:57:43 UTC 13.3K followers, 1934 engagements "$CNVI.v $CNVIF's CEO: "The market risk is really low at this level. In fact it's a hot time in the market for products like ours. Our technology risk has been retired with regard to our next generation development & regulatory risk will be low because we have a 510K application with our own product at as its predicate and lastly our our finance or capital risk has been reduced because we have just raised $XX million in financing.""  [@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1940838461444870388) 2025-07-03 18:22:02 UTC 13.3K followers, 2215 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Joe posts on X about $srpt, sarepta therapeutics, $atbpf, $lib the most. They currently have XXXXXX followers and 1561 posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks finance cryptocurrencies countries
Social topic influence $srpt #180, sarepta therapeutics, $atbpf, $lib #1, $vltlf #1, $vrtx, $ateto, $cricf, $criv, longterm
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Vertex Protocol (VRTX) AST SpaceMobile, Inc. Class A Common Stock (ASTS)
Top posts by engagements in the last XX hours
"$VLTLF $LIB The results from the Field Trial confirmed the performance against the R&D Centre by achieving an average XX% lithium extraction rate from Bakkenregion oilfield brine. The field trial was conducted at Compass Energy Systems Blue Marlin salt-water-disposal facility #NorthDakota" @Gantosj on X 2025-07-17 17:34:20 UTC 13.3K followers, 3060 engagements
"$CRI.v $CRICF continue to surprise the street with high grade Zinc results & up another XXXXX% today to C$0.095 on huge volume 3.2M shares Sophisticated mining investors are joining Churchill Reports High-Grade Zinc Results on Polymetallic Veinsat the Black Raven Property Central Newfoundland" @Gantosj on X 2025-07-08 16:58:36 UTC 13.3K followers, 2042 engagements
"$SRPT is eligible to receive up to $103.5M in near-term regulatory and commercial milestone payments Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS a Gene Therapy to Treat Duchenne Muscular Dystrophy" @Gantosj on X 2025-05-13 13:47:36 UTC 13.3K followers, 2758 engagements
"$SRPT Strategic restructuring includes reduced operating expenses delivering approximately $XXX million in anticipated annual cost savings and implementing a XX% workforce reduction of approximately XXX employees" @Gantosj on X 2025-07-16 20:05:11 UTC 13.3K followers, 11.2K engagements
"$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label" @Gantosj on X 2025-07-16 20:03:12 UTC 13.3K followers, 4058 engagements
"Actually $ATBPF $ATE.to reiterate the Ph-2 "On track to launch upgraded Ph-2 abdominoplasty trial in March 2024" What I like about the Ph-2 in pain that it's fast to recruit & to get the data since the follow-up is for a very short period of X week. So results would be released in Q3" @Gantosj on X 2024-02-21 14:26:16 UTC 13.3K followers, 2246 engagements
"$CRI.v $CRICF Insiders are buying new CEO Conan bought 2million shares & holding total of 7.1M shares. Also Malik the largest shareholder bough another 1M shares to get a total of 34.46M shares Insiders can sell for multiple reasons but they will buy for only ONE reason CONFIDENCE in the company & LT opportunity Another #Polymetallic discovery in #Canada" @Gantosj on X 2025-07-11 15:20:48 UTC 13.3K followers, 2008 engagements
"Interesting $ATBPF $ATE.to is going for pivotal trial Ph-2 trial enhancements include the use of a placebo arm an increased sample size to XXX patient & the use of adaptive design methodology these enhancements may enable it to qualify as a pivotal trial for the FDA" @Gantosj on X 2024-02-14 12:15:56 UTC 13.3K followers, 1524 engagements
"The key to the kingdom is going to be onset. It's where $VRTX failed with VX-548 Ask yourself would you take a drug that needs X hours to show any meaningful effect after bunion surgery Or 2hrs after tummy-tuck surgery Patients will call the nurse every 10min $ATBPF 60min - Safe next-generation #NSAID with enhanced safety for stand-alone or multimodal use" @Gantosj on X 2024-01-31 13:44:33 UTC 13.3K followers, 3662 engagements
"$CNVIF $CNVI.v Capital structure Way undervalued when we look at many M&A deals in cardiovacular space & many large medical devices would try to get the hybrid device & add it to their imaging portfolio that gives CNVI a multibagger potential in a very short time" @Gantosj on X 2025-06-12 18:19:34 UTC 13.3K followers, 4554 engagements
"Just think about this #Undervalued & Under-The-Radar investment with a multibagger potential $VLTLF $LIB The Permian Basin in #Texas generates 19million barrels per day of brine at lithium concentrations avg. 30ppm translating to a conservative 170000 tonnes per annum of potential LCE. The Williston Basin Bakken in #NorthDakota production ranges from 1.6million to 2m barrels of brine per day suggesting potential production of 50000 tpa LCE. X Tonne of #Lithium in the US worth around $15K-20K" @Gantosj on X 2025-07-17 19:00:49 UTC 13.3K followers, 4857 engagements
"$SRPT Sarepta Therapeutics Shares New Protein Expression and Safety Results from ENDEAVOR in Participants X Years Old at Time of Treatment" @Gantosj on X 2025-05-16 13:02:45 UTC 13.3K followers, 7808 engagements
"This non-opioid #pain drug in very interesting with potential to become Best-in-Class #NSAID with no to very low risk of GI AEs & bleeding #ulcer $ATBPF $ATE.to will start Ph-2 trial in Q1-2024 so any time during March is expected" @Gantosj on X 2024-02-20 17:01:31 UTC 13.3K followers, 2507 engagements
"$SRPT New protocol for immunosuppressive regimen with X months study" @Gantosj on X 2025-07-16 20:51:57 UTC 13.3K followers, 7895 engagements
"When it comes to innovation & new technology investing in $VLTLF $LIB these days reminds me of the tough days $ASTS investors went through when short-sellers were steering the price & exploiting every delay or financing uncertainty. Back in April 2024 $ASTS plummeted to a 52-week low of $XXXX & fast forward to today ASTS become a favorite among loyal investors who held firm & kept averaging down. Now $ASTS trading at $XX with even more upside potential ahead its a reminder of the power of conviction and patience @spacanpanman @ASTS_SpaceMob @ASTS_Investors @fierro7676 @StunningFeline" @Gantosj on X 2025-07-17 19:37:32 UTC 13.3K followers, 4725 engagements
"$SRPT Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs U.S. FDA has confirmed that screening and dosing may proceed in Study SRP-9005-101 for LGMD2C/R5" @Gantosj on X 2025-04-15 12:35:32 UTC 13.3K followers, 4625 engagements
"$SRPT Duchenne portfolio continues to deliver stable and robust revenues with preliminary quarterly results showing total net product revenue of $XXX million for the second quarter 2025" @Gantosj on X 2025-07-16 20:07:08 UTC 13.3K followers, 13.5K engagements
"$SRPT Sarepta Therapeutics to Announce First Quarter 2025 Financial Results Tuesday May X 2025. and conference call at 4:30pm ET" @Gantosj on X 2025-04-22 12:57:43 UTC 13.3K followers, 1934 engagements
"$CNVI.v $CNVIF's CEO: "The market risk is really low at this level. In fact it's a hot time in the market for products like ours. Our technology risk has been retired with regard to our next generation development & regulatory risk will be low because we have a 510K application with our own product at as its predicate and lastly our our finance or capital risk has been reduced because we have just raised $XX million in financing."" @Gantosj on X 2025-07-03 18:22:02 UTC 13.3K followers, 2215 engagements
/creator/twitter::Gantosj